Back
ESC Professional Premium Access

In a large dataset of primary care patients, use of CHA2DS2-VA score leads to almost universal recommendation for anticoagulation in those aged 65 years and over with atrial fibrillation

Session: Cardiovascular risk assessment and scores
Topic: Scores
Speaker: Doctor J. Orchard (Sydney, AU)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Jessica Orchard

University of Sydney, Sydney (Australia)
3 presentations
0 follower

7 more presentations in this session

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

Speaker: Doctor S. Hageman (Utrecht, NL)

Access
Abstract
Slides
Thumbnail

Potential impact of replacing SCORE with SCORE-2 on risk classification and statin eligibility - a coronary calcium score correlation study

Speaker: Miss M. Paiva (Lisbon, PT)

Access
Abstract
Slides
Thumbnail

Associations of SCORE2, circulating cardiovascular biomarkers and carotid intima-media-thickness in a population-based cohort

Speaker: Doctor B. Toprak (Hamburg, DE)

Access
Abstract
Slides
Thumbnail

Comparison between the European SCORE and the updated SCORE2 for cardiovascular outcomes

Speaker: Doctor M. Temtem (Funchal, PT)

Access
Abstract
Slides
Thumbnail

Distribution of cardiovascular disease risk according to SCORE2 and potential need for cholesterol and blood pressure lowering therapy in apparently healthy middle-aged individuals

Speaker: Doctor A. Yari (Stockholm, SE)

Access
Abstract
Slides
Thumbnail

Access the full session

Cardiovascular risk assessment and scores

Speakers: Doctor J. Orchard, Doctor S. Hageman, Miss M. Paiva, Doctor B. Toprak, Doctor M. Temtem...
Access
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb